Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

These 27 eye products could lead to infections and vision loss, FDA warns

If you find one of the products in your home you need to dispose of it immediately, the FDA says

The Independent UK

Verve Stock Soars On $250 Million Eli Lilly Deal

Lilly will pay $250 million to Beam for the rights to three gene-editing drugs from Verve. VERV stock and Beam stock skyrocketed.

Investors Business Daily

Pharmacists prescribe another round of US protests to highlight working conditions

Drugstore employees around the country have started calling in sick to highlight a lack of support from their employers

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

White House urges all US schools to stock overdose reversal drug naloxone

Letter from education department presses for schools to train students and faculty in how to administer medication

The Guardian - US

New Unilever boss is still getting it wrong on Russia

The Dove and Magnum maker says it wants to make a ‘positive impact’ but pays taxes to a state waging an illegal war in Ukraine

The Guardian - UK

Amgen (AMGN) Earnings Watch: Buy or Sell?

Amgen (AMGN) is scheduled to report its third-quarter earnings soon, with Wall Street analysts expecting year-over-year improvements in revenue. However, its earnings are expected to miss the consensus estimate. Moreover, the company completed the acquisition of Horizon Therapeutics earlier this month. Considering these factors, is the stock a buy or…

StockNews.com

Life-saving overdose reversal drug expanded across Scotland

Community pharmacies across Scotland are being provided with a drug which can reverse overdoses.

The National (Scotland)

Read news from The Economist, FT, and more,
with one subscription

COVID-19 treatments to enter the market with a hefty price tag

The COVID-19 treatments millions of have taken for free from the federal government will enter the private market next week with a hefty price tag

The Independent UK

US government says it plans to go after legal goods tied to illegal fentanyl trade in new strategy

The U.S. Customs and Border Protection has announced a new government-wide strategy that will target not only fentanyl but precursor materials used to make the synthetic opioid

The Independent UK

Biogen Pulls Prothena Into A Steep Dive On Mixed Results For Alzheimer's Treatment

Biogen stock tumbled Thursday — pulling Prothena stock down — on mixed test results for an updated version of its Alzheimer's treatment.

Investors Business Daily

3 Pharma Stocks With Market Impact to Consider Buying

The pharmaceutical sector is expected to thrive due to the rising demand for advanced medicines to treat lifestyle diseases and its increasing ability to meet quality treatment needs thanks to technological advancements. Therefore, it could be wise to add fundamentally strong pharma stocks Amneal Pharmaceuticals (AMRX), Dr. Reddy’s Laboratories (RDY),…

StockNews.com

Cardinal Health Nears Buy Point As Earnings Approach For Drug Distributor

This leading health stock is near all-time highs and in a base. Shares have outperformed the S&P 500 this year.

Investors Business Daily

3 Pharma Stocks on the Rise - Buy Now

The pharmaceutical industry is well-positioned for long-term growth thanks to rising investments in drug development and technological advancements. Thus, it would be prudent to buy pharma stocks, Sanofi (SNY), Johnson & Johnson (JNJ) and AstraZeneca PLC (AZN). Read on.

StockNews.com

Amgen cuts Horizon Therapeutics jobs at Deerfield office after acquisition

350 people will be laid off, many of them at Horizon’s U.S. base in Deerfield.

Chicago Sun-Times

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Top-Notch Medpace Smashes Forecasts And Rockets 20% Toward A Record

Medpace Holdings easily beat third-quarter forecasts on Tuesday and netted a bullish number of new contracts. MEDP stock surged.

Investors Business Daily

Alkermes Plummets In Huge Volume. Why One Analyst Says The Reaction Is Overdone.

Alkermes stock plummeted to its lowest price since last December on disappointing test results for its experimental narcolepsy treatment.

StockNews.com

3 Healthcare Stocks With Strong Stability

The healthcare industry is well-positioned for expansion due to rising healthcare expenditures and growing demand for quality treatment. Given the industry’s solid long-term prospects, investors might consider buying quality stocks Cigna (CI), UnitedHealth Group (UNH) and Elevance Health (ELV). Read on….

WEKU

The hospital ran out of her child's cancer drug. Now she's fighting to end shortages

Laura Bray couldn't watch her 9-year-old's leukemia go untreated. She started campaigning to fix a broken system and get patients the treatments they need in the face of drug shortages.

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

Law enforcement eyes opioid settlement cash for squad cars and body scanners

Some state and local governments have started tapping in to opioid settlement funds for law enforcement expenses. Many argue it should go toward treating addiction instead.

Investors Business Daily

Pfizer Hikes Paxlovid Price To $1,390 — More Than Double What The Government Paid

Pfizer is hiking its Paxlovid price to $1,390 for a five-day course of the Covid pill. But Pfizer stock fell early Thursday.

Investors Business Daily

Drug Giant Roche Skids As Covid Products Decline Weighs On Sales, Guidance

Roche stock skidded early Thursday after the Swiss drugmaker said declining demand for Covid products weighed on third-quarter sales.

StockNews.com

3 Revolutionary Biotech Stocks Worth Investing In

The biotech industry's upward momentum is underpinned by the growth of personalized medicine, orphan drugs, innovative biotech tools, and robust government backing. Hence, revolutionary biotech stocks Equillium (EQ), Protalix BioTherapeutics (PLX), and Incyte Corporation (INCY) could make ideal additions to your portfolio at present. Read more….

Newsroom.co.nz

Medsafe overrides its Medicines Classification Committee on cannabis

The committee advised against over-the-counter CBD sales late last year

StockNews.com

3 Promising Pharma Stocks to Keep on Your Radar

The pharma industry’s prospects look bright, thanks to rising demand for generic and innovative drugs and technological advancements. Hence, adding fundamentally strong pharma stocks Astellas Pharma (ALPMY), Sanofi (SNY), and GSK (GSK) to one’s watchlist could be wise. Keep reading.

StockNews.com

3 Biotech Stocks for Long-Term Value

With medical innovations and a rising geriatric population, biotech stocks have garnered significant attention. Thus, sound biotech stocks like Genfit (GNFT), Entrada Therapeutics (TRDA), and MacroGenics (MGNX) could prove to be valuable portfolio additions in the long term. Read on….

1 … 35 36 37 38

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Scottish Government

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.